Krishnan-Sarin Suchitra, Krystal John H, Shi Julia, Pittman Brian, O'Malley Stephanie S
Department of Psychiatry, Yale University School of Medicine, Connecticut Mental Health Center, 34 Park Street, New Haven, CT 06519, USA.
Biol Psychiatry. 2007 Sep 15;62(6):694-7. doi: 10.1016/j.biopsych.2006.11.018. Epub 2007 Mar 6.
The purpose of this study was to examine the interactive effects of family history of alcoholism (FH+, FH-) and naltrexone dose (0, 50, 100 mg/day) on alcohol drinking.
Ninety-two, non-treatment-seeking alcohol-dependent participants received naltrexone daily for 6 days. On the 6th day, they participated in a laboratory paradigm involving exposure to a priming dose of alcohol followed by a 2-hour drinking period in which they made choices between consuming alcoholic drinks and receiving money.
Total number of drinks consumed during the drinking period was significantly decreased by the 100-mg dose of naltrexone in FH+ drinkers. Secondary analyses in male drinkers (n = 70) indicated that 100 mg of naltrexone significantly decreased drinking in FH+ participants and increased drinking in FH- drinkers.
These results suggest that family history of alcoholism might be a significant clinical predictor of response to naltrexone and that FH+ men are more likely to benefit from naltrexone therapy for alcohol drinking.
本研究旨在探讨酒精中毒家族史(FH +,FH -)和纳曲酮剂量(0、50、100毫克/天)对饮酒的交互作用。
92名未寻求治疗的酒精依赖参与者每天服用纳曲酮,持续6天。在第6天,他们参与了一个实验室范式,包括接触一次酒精启动剂量,随后是一个2小时的饮酒期,在此期间他们要在饮用酒精饮料和获得金钱之间做出选择。
在FH +饮酒者中,100毫克剂量的纳曲酮显著减少了饮酒期饮用的饮料总数。对男性饮酒者(n = 70)的二次分析表明,100毫克纳曲酮显著减少了FH +参与者的饮酒量,并增加了FH -饮酒者的饮酒量。
这些结果表明,酒精中毒家族史可能是对纳曲酮反应的一个重要临床预测指标,并且FH +男性更有可能从纳曲酮治疗饮酒中获益。